The Fanconi anemia/BRCA pathway is involved in DNA interstrand cross-link repair of adriamycin-resistant leukemia cells

Leukemia and Lymphoma

Volumn 56, Issue 3, 2015, Pages 755-762

  Yao, Chenjiao ^a,b   Du, Wei ^a   Chen, Haibing ^a   Xiao, Sheng ^a   Huang, Lihua ^a   Chen, Fangping ^b  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

DNA interstrand cross link repair; drug resistance; FA BRCA pathway; leukemia

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; BRCA1 PROTEIN; BRCA2 PROTEIN; DOXORUBICIN; FANCF PROTEIN, HUMAN; FANCONI ANEMIA GROUP F PROTEIN;

APOPTOSIS; CELL CYCLE; CELL SURVIVAL; DNA DAMAGE; DNA REPAIR; DOSE RESPONSE; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION; GENETICS; HUMAN; K562 CELL LINE; LEUKEMIA; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BLOTTING, WESTERN; BRCA1 PROTEIN; BRCA2 PROTEIN; CELL CYCLE; CELL SURVIVAL; DNA DAMAGE; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FANCONI ANEMIA COMPLEMENTATION GROUP F PROTEIN; GENE EXPRESSION; HUMANS; K562 CELLS; LEUKEMIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84924666867     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2014.935363     Document Type: Article

References (26)

1. Saffi J, Agnoletto MH, Guecheva TN, et al. Effect of the anti-neoplastic drug doxorubicin on XPD-mutated DNA repair-deficient human cells. DNA Repair (Amst) 2010;9:40-47.
2. Moldovan GL, D'Andrea AD. How the fanconi anemia pathway guards the genome. Annu Rev Genet 2009;43:223-249.
3. Kim H, D'Andrea AD. Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes Dev 2012;26:1393-1408.
4. Romick-Rosendale LE, Lui VW, Grandis JR, et al. The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma. Mutat Res 2013;743-744:78-88.
5. D'Andrea AD. Targeting DNA repair pathways in AML. Best Pract Res Clin Haematol 2010;23:469-473.
6. Ciccia A, Ling C, Coulthard R, et al. Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol Cell 2007;25:331-343.
7. Ling C, Ishiai M, Ali AM, et al. FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway. EMBO J 2007;26:2104-2114.
8. Leveille F, Blom E, Medhurst AL, et al. The Fanconi anemia gene product FANCF is a flexible adaptor protein. J Biol Chem 2004;279:39421-39430.
9. Garcia-Higuera I, Kuang Y, Denham J, et al. The fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex. Blood 2000;96:3224-3230.
10. Gordon SM, Buchwald M. Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems. Blood 2003;102:136-141.
11. de Winter JP, van der Weel L, de Groot J, et al. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet 2000;9:2665-2674.
12. Ueda F, Sumi K, Tago K, et al. Critical role of FANCC in JAK2 V617F mutant-induced resistance to DNA cross-linking drugs. Cell Signal 2013;25:2115-2124.
13. Chen Q, Van der Sluis PC, Boulware D, et al. The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells. Blood 2005;106:698-705.
14. Xiao H, Xiao Q, Zhang K, et al. Reversal of multidrug resistance by curcumin through FA/BRCA pathway in multiple myeloma cell line MOLP-2/R. Ann Hematol 2010;89:399-404.
15. Chen CC, Taniguchi T, D'Andrea A. The Fanconi anemia (FA) pathway confers glioma resistance to DNA alkylating agents. J Mol Med (Berl) 2007;85:497-509.
16. Taniguchi T, Tischkowitz M, Ameziane N, et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med 2003;9:568-574.
17. Mathew CG. Fanconi anaemia genes and susceptibility to cancer. Oncogene 2006;25:5875-5884.
18. Crossan GP, Patel KJ. The Fanconi anaemia pathway orchestrates incisions at sites of crosslinked DNA. J Pathol 2012;226:326-337.
19. Knipscheer P, Raschle M, Smogorzewska A, et al. The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair. Science 2009;326:1698-1701.
20. Kuraoka I, Kobertz WR, Ariza RR, et al. Repair of an interstrand DNA cross-link initiated by ERCC1-XPF repair/recombination nuclease. J Biol Chem 2000;275:26632-26636.
21. Niedzwiedz W, Mosedale G, Johnson M, et al. The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol Cell 2004;15:607-620.
22. Yarde DN, Oliveira V, Mathews L, et al. Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myeloma. Cancer Res 2009;69:9367-9375.
23. Rothfuss A, Grompe M. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol Cell Biol 2004;24;123-134.
24. Wang X, Li DH. Adriamycin-induced apoptosis of tumor cells: research progress. China Pract Med 2010;7:247-249.
25. Lundholm L, Haag P, Zong D, et al. Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest. Cell Death Dis 2013;4:478.
26. Wha JD, Hwang M, Kim HJ, et al. Ouabain, a cardiac glycoside, inhibits the Fanconi anemia/BRCA pathway activated by DNA interstrand cross-linking agents. PLoS One 2013;8:75905.